Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
Shaohua Fan, Qianfeng Xiong, Lei Wang, Lihui Zhang, Yawei Shi
Topics & Concepts
Vascular remodelling in the embryoDownregulation and upregulationVascular smooth muscleInternal medicineEndocrinologyLiraglutideMatrix metalloproteinaseAngiotensin IIMedicineDipeptidyl peptidase-4Extracellular matrixChemistryPharmacologyCell biologyReceptorDiabetes mellitusBiologyType 2 diabetesBiochemistrySmooth muscleGeneDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisNeuropeptides and Animal Physiology